7 Results for "

p53-MDM2 binding inhibitor

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "p53-MDM2 binding inhibitor" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-15335
CAS No.: 675576-97-3
Purity:  98.78%
Research Areas:  

Cancer

Nutlin-3b, the inactive form of Nutlin-3 (HY-50696), is a p53/MDM2 inhibitor with an IC50 of 13.6 μM. Nutlin-3b is 150 times less potent in binding to MDM2 than Nutlin-3a (HY-10029). Nutlin-3b is promising for research of cancers .
loading...
    loading...
Cat. No.: HY-100383
CAS No.: 300817-68-9
Purity:  ≥98.0%
Synonyms: BHI1
Research Areas:  

Cancer

BH3I-1 is a Bcl-2 family antagonist, which inhibits the binding of the Bak BH3 peptide to Bcl-xL with a Ki of 2.4±0.2 μM in FP assay. BH3I-1 has a Kd of 5.3 μM against the p53/MDM2 pair.
loading...
    loading...
Cat. No.: HY-16999
CAS No.: 1309684-94-3
Research Areas:  

Cancer

RO8994 (Compound 4) is an orally active, highly potent and selective spiroindolinone p53-MDM2 inhibitor with an IC50 value of 5 nM (HTRF binding assays) and 20 nM (MTT proliferation assays). RO8994 induces up-regulation of p53 expression and Apoptosis in wild-type p53 cancer cells. RO8994 also inhibits tumor growth in the tumor xenograft model .
loading...
    loading...
Cat. No.: HY-15676A
Purity:  99.18%
Synonyms: RG7388 (enantiomer)
Research Areas:  

Cancer

Idasanutlin enantiomer is the isomer of Idasanutlin (HY-15676), and can be used as an experimental control. Idasanutlin (RG7388) is a potent and selective MDM2 antagonist, inhibiting p53-MDM2 binding, with an IC50 of 6 nM.
loading...
    loading...
Cat. No.: HY-149250
CAS No.: 3043723-74-3
Target:  

MDM-2/p53 Apoptosis

Research Areas:  

Cancer

MDMX/MDM2-IN-2 is a potent p53-MDM2/MDMX dual inhibitors with Kis of 0.23 μM and 2.45 μM for MDM2 and MDMX, respectively. MDMX/MDM2-IN-2 inhibits the binding of p53 and MDM2 proteins. MDMX/MDM2-IN-2 restores the function of p53 and enables cell cycle arrest and apoptosis. MDMX/MDM2-IN-2 inhibits cell migration and invasion. MDMX/MDM2-IN-2 has antitumor activity .
loading...
    loading...
Cat. No.: HY-119014
CAS No.: 878022-36-7
Research Areas:  

Cancer

NU-8231 (Compound 2) is a p53-MDM2 binding inhibitor with an IC50 of 5.3-200 μM for inhibiting the p53-MDM2 interaction. NU-8231 is applicable for cancer research .
loading...
    loading...
Cat. No.: HY-107466
CAS No.: 1067654-70-9
Target:  

MDM-2/p53

Research Areas:  

Cancer

WK298 is a potent inhibitor of the MDM2/MDMX-p53 interaction with good anti-tumor activity. WK298 can fully activate the p53 pathway by inhibiting the binding of MDM2 and MDMX to p53. The development of WK298 benefited from a deep understanding of the key elements of the p53-MDM2/MDMX interaction structure .
loading...
    loading...